According to Lyra Therapeutics's latest financial reports the company's current EPS (TTM) is -20,61ย โฌ. In 2024 the company made an earnings per share (EPS) of -60,26ย โฌ a decrease over its 2023 EPS that were of -53,10ย โฌ.